Crossover Drug-Drug Interaction Study to Determine Effects of Cytochrome P450 3A on Exposure to Mifepristone and Its Metabolites
Clinical trial NCT03258372 · COMPLETED
Trial details
- NCT number
- NCT03258372
- Sponsor
- Corcept Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-16
- Primary completion
- 2017-11-29
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.